Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
2.89 +0.13 / +4.71%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.89 0.00 / 0.00%
 
Volume: 11.2K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues30.9M23.0M4.4M5.2M
 
 
 
 
 
Depreciation And Amortization41.0K52.0K51.0K52.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses17.8M20.5M19.8M25.9M
 
 
 
 
 
Research And Development10.7M13.0M11.2M15.1M
 
 
 
 
 
Total Operating Expenses17.8M20.6M19.8M25.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income13.0M2.4M-15.5M-20.7M
 
 
 
 
 
Interest Expense On Debt1.8M1.8M1.8M1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income11.3M607.0K-17.2M-22.5M
 
 
 
 
 
Net Income11.3M607.0K-17.2M-22.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS122.6M123.0M123.9M125.2M
 
 
 
 
 
Shares To Calculate EPS Diluted130.1M123.0M123.9M125.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.09$0.00-$0.14-$0.18
 
 
 
 
EPS Diluted$0.09$0.00-$0.14-$0.18